51. Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications.
- Author
-
Williams CK, Cuttner J, Ohnuma T, Ambinder EP, Ferreira PP, and Holland JF
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Bacterial Infections etiology, Female, Humans, Iatrogenic Disease chemically induced, Infections etiology, Leukemia, Myeloid, Acute complications, Leukemia, Myeloid, Acute drug therapy, Male, Middle Aged, Prognosis, Antineoplastic Combined Chemotherapy Protocols adverse effects, Iatrogenic Disease etiology, Leukemia, Myeloid, Acute chemically induced
- Abstract
We have compared the clinical and laboratory features as well as treatment complications observed in 6 patients with iatrogenic acute myelogenous leukemia (I-AML) with those of 26 patients with idiopathic acute myelogenous leukemia (AML). I-AML patients were significantly younger and their disease appeared less virulent on admission than in the AML patients. Following identical chemotherapy, hemorrhagic complications and the need for platelet support were found to be similar for both groups. Major infections, including systemic candidiasis and Gram-negative septicemias, occurred 3 times more frequently among I-AML than AML patients. More marked suppression and delayed regeneration of the bone marrow also occurred in I-AML patients. These observations and other factors, such as post-splenectomy state and inherent immune deficiency among surgically staged lymphoma patients as well as radiation induced immunologic impairment, may have contributed to the increased propensity to develop infection observed in this group of patients. Five of the 6 I-AML and 17 of the 26 AML patients achieved remission. We attribute the satisfactory outcome in our I-AML patients to treatment in a protective environment and availability of facilities for hematologic supportive care.
- Published
- 1987
- Full Text
- View/download PDF